Crean David Hugh 4
4 · Histogen Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Crean David Hugh
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+1,000→ 1,000 totalExercise: $3.20Exp: 2032-06-01→ Common Stock (1,000 underlying)
Footnotes (3)
- [F1]On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 and the exercise price have been adjusted to reflect the Reverse Stock Split.
- [F2]This option was issued to the Reporting Person, a non-employee director of the Issuer, for his service as a director of the Issuer.
- [F3]The shares subject to this option become fully vested and exercisable on 6/1/2023, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.